545825: FAMOTIDINE INJECTION.
The FAMOTIDINE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, total_primary_container_quantity: 25, primary_container_content_quantity: 2.0 MILLILITERS, part_name_assigned_by_controlling_agency: FAMOTIDINE INJECTION, 20 MG/2 ML, 25S, SINGLE DOSE VIAL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-689-6023, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | VIAL |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 2.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | FAMOTIDINE INJECTION, 20 MG/2 ML, 25S, SINGLE DOSE VIAL |
| NSN | 6505-01-689-6023 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | FAMOTIDINE INJECTION, SUPPLIED AS A CONCENTRATED SOLUTION FOR INTRAVENOUS INJECTION, IS INTENDED FOR INTRAVENOUS USE ONLY AFTER DILUTION; STORE FAMOTIDINE INJECTION AT 2 TO 8 C (36 TO 46 F), IF SOLUTION FREEZES, BRING TO ROOM TEMPERATURE; SHELF LIFE IS 24 MONTHS; PACK OF 25 VIALS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FAMOTIDINE INJECTION, 20 MG/2 ML, 25S, SINGLE DOSE VIAL |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |